AcroMetrix Launches PeliSpy Chagas Positive Control

Armen Hareyan's picture
Advertisement

Chagas Disease

AcroMetrix launched of the PeliSpy Chagas Disease Positive Control. This external run control is intended to provide the laboratory a means of estimating precision and reproducibility of assays that detect antibodies to the Trypanosoma cruzi (T. cruzi) parasite, the cause of Chagas disease.

Advertisement

Chagas disease is a potentially deadly infection which often does not exhibit symptoms for up to 40 years. It is now endemic to most of Central and South America, with an increasing number of new cases reported in the US every year.

Some experts estimate as many as 100,000 legal immigrants to the US and Canada are unknowingly infected with T. cruzi. The parasite may be spread through contact with insect feces, congenital transmission, organ transplantation, or blood transfusion.

Routine use of the PeliSpy Chagas Positive external run control can help laboratories to monitor the day-to-day performance of their Chagas assay, including consistency between reagent lots and operator variation. PeliSpy Chagas Positive Controls are packaged ready-to-use and are developed to closely mimic an actual patient sample. This product is for Research Use Only. Not for use in diagnostic procedures.

Advertisement